Treatment of BM-MNCs with LY294002 showed patient- and culture-dependent patterns of CD138+ myeloma cell death and M1/M2 macrophage ratio, contrasting the observed consistent responses in U266 mono-culture. The gene discussed is SDC1; the disease is plasma cell myeloma.